—

AstraZeneca PLC (AZN.L) — the peer cohort

As of 2026-11-13 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

AstraZeneca PLC ranks 10 of 11 in its cohort on the Closelooknet composite (55/100) — the cohort is led by Halozyme Therapeutics Inc at 72/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
AZN.L AstraZeneca PLC 55 61 75 45 info 9.6%
LLY Eli Lilly and Company 64 92 90 22 neutral 2.2%
SAN.PA Sanofi SA 64 75 70 64 bull 0.6%
ORNAV.HE Orion Oyj A 63 94 84 29 ok 0.8%
ORNBV.HE Orion Oyj B 63 93 84 29 ok 1%
NVO Novo Nordisk A/S 56 29 86 72 neutral 34.3%
AMGN Amgen Inc 55 88 85 34 neutral 3.5%
HALO Halozyme Therapeutics Inc 72 73 94 49 info 25.2%
ONC BeOne Medicines AG 65 89 64 29 ok 1.9%
REGN Regeneron Pharmaceuticals Inc 65 87 72 46 neutral 4.1%
ANN.AU Ansell Ltd 64 96 48 50 ok 1.9%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-13

Quick answers

Who are AstraZeneca PLC's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Eli Lilly and Company (LLY), Sanofi SA (SAN.PA), Orion Oyj A (ORNAV.HE), Orion Oyj B (ORNBV.HE), Novo Nordisk A/S (NVO), Amgen Inc (AMGN), Halozyme Therapeutics Inc (HALO), BeOne Medicines AG (ONC) and others, as of 2026-11-13.

How does AZN.L score against its peers?

AstraZeneca PLC's composite reads 55/100, ranking 10 of 11 in its cohort as of 2026-11-13; the cohort's highest composite is Halozyme Therapeutics Inc at 72/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.